About US
Contact us
-
Who's your pick for the next FDA chief? Nominate now, start voting next weekBefore President-elect Joe Biden announces his own choice for the FDA top spot, Fierce Pharma wants to know what readers think. Who do you think is the best man or woman to serve as the nation’s next2020/12/2
-
Amgen, Takeda and UCB join forces in new COVID-19 drug repurposing studyEven as the FDA has already approved or authorized several COVID-19 drugs, the search for better therapies is still underway—and despite some high-profile failures, repurposing existing drugs remains2020/12/1
-
Pharma AstraZeneca hands European Crestor rights to old customer Grünenthal for $350MAstraZeneca has reached for the ax again, with old cholesterol blockbuster Crestor its latest target. The British pharma hasagreed to sellCrestor rights in more than 30 European countries to Grünenth2020/12/1
-
Why isn't Pfizer's COVID-19 vaccine OK'd yet? White House calls in FDA chief Hahn to explain: AxiosThroughout the pandemic, White House officials have twisted arms at the FDA—and sometimes succeeded.Now, in the final months ofthe Trump administration, agency chief Stephen Hahn, M.D., has been summ2020/11/30
-
AstraZeneca staffers targeted in suspected hacking scheme amid work on COVID-19 vaccine: reportAfter China, Iran and Russia, North Korea is the latest to be fingered for attempting to steal Western research intoCOVID-19. Its target? AstraZeneca. North Korean hackersusedsham recruiting schemes2020/11/27
-
McKinsey consultants proposed Purdue offer rebates for opioid overdoses: NYTPurdue Pharma has faced years ofintensescrutiny over its opioid painkiller marketing, culminating withlast month’sDepartment of Justice settlement worth more than $8 billion.Behind the scenes,global2020/11/27
-
Pfizer marks first 'mass air shipment' of COVID-19 shot amid cold-chain scrutinyPfizer, alone among its peers, has faced fever-pitchscrutiny over the stringent cold storage requirements for its COVID-19 vaccine—and the logistical challenges that could pose. Looking to ease the d2020/11/26
-
Novavax, swamped with FDA's manufacturing 'questions,' hopes for US coronavirus shot trial within the yearWith two players in the race for a COVID-19 vaccine nearing the finish line on world-first regulatory approvals, Maryland biotech Novavax continues to lag behind in getting its candidate into a late-2020/11/26
-
Fierce Pharma Politics—Canada restricts U.S. drug exports after Trump executive orderWelcome to theFiercePharmapolitical roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewherethat could affect drug pricing and howdrugmakersoperate. After President2020/11/25
-
Rhythm Pharmaceuticals scores first FDA approval for obesity med targeting genetic defectsObesity is a major problem worldwide, but, for a fraction of patients, genetic mutations rather than habits are driving the disease. With its new FDA approval for Imcivree, Rhythm Pharmaceuticals is2020/11/24